It’s show-me time for batoclimab, an antibody treatment from Immunovant and Roivant Sciences. Here's what you need to know.

Treatments for myasthenia gravis include medications ... Plasmapheresis may cause a drop in blood pressure. Intravenous immunoglobulin (IVIG): This treatment involves the infusion of healthy ...

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia ... be used concomitantly with intravenous immunoglobulin and plasma exchange ...

But one of the rarest muscular disorders is also one of the most concerning. It's called myasthenia gravis and affects only about 37 out of every 100,000 people in the United States. Despite being ...

Hansa Biopharma AB (HNSBF) reports a robust 35% increase in IDEFIRIX sales and expands its European market presence, despite facing revenue fluctuations and operating losses.